0000950142-24-001494.txt : 20240530 0000950142-24-001494.hdr.sgml : 20240530 20240530181110 ACCESSION NUMBER: 0000950142-24-001494 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240530 FILED AS OF DATE: 20240530 DATE AS OF CHANGE: 20240530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MANHARD KIMBERLY CENTRAL INDEX KEY: 0001202094 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42031 FILM NUMBER: 241007002 MAIL ADDRESS: STREET 1: C/O HERON THERAPEUTICS, INC STREET 2: 4242 CAMPUS POINT COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inhibrx Biosciences, Inc. CENTRAL INDEX KEY: 0002007919 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 990613523 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11025 N. TORREY PINES ROAD, SUITE 140 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 795-4220 MAIL ADDRESS: STREET 1: 11025 N. TORREY PINES ROAD, SUITE 140 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: Ibex SpinCo, Inc. DATE OF NAME CHANGE: 20240111 4 1 es240484864_4-manhard.xml OWNERSHIP DOCUMENT X0508 4 2024-05-30 0 0002007919 Inhibrx Biosciences, Inc. INXB 0001202094 MANHARD KIMBERLY C/O INHIBRX BIOSCIENCES, INC. 11025 NORTH TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 1 0 0 0 0 Stock Option (right to buy) 15.86 2024-05-30 4 A 0 30000 0.00 A 2034-05-30 Common Stock 30000 30000 D This stock option was granted following the consummation of the merger of Inhibrx, Inc. with a wholly owned indirect subsidiary of Sanofi. This stock option will be fully exercisable on May 30, 2025, subject to the reporting person's continued service through such date. /s/ Kelly D. Deck, Chief Financial Officer of Inhibrx Biosciences, Inc., attorney-in-fact 2024-05-30